GB2552697A - Process for the preparation of boscalid - Google Patents
Process for the preparation of boscalid Download PDFInfo
- Publication number
- GB2552697A GB2552697A GB1613458.7A GB201613458A GB2552697A GB 2552697 A GB2552697 A GB 2552697A GB 201613458 A GB201613458 A GB 201613458A GB 2552697 A GB2552697 A GB 2552697A
- Authority
- GB
- United Kingdom
- Prior art keywords
- boscalid
- process according
- chloro
- reaction mixture
- biphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000005740 Boscalid Substances 0.000 title claims abstract description 100
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 title claims abstract description 100
- 229940118790 boscalid Drugs 0.000 title claims abstract description 100
- 238000000034 method Methods 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title claims description 10
- 230000004048 modification Effects 0.000 claims abstract description 44
- 238000012986 modification Methods 0.000 claims abstract description 44
- 239000011541 reaction mixture Substances 0.000 claims abstract description 42
- 238000006243 chemical reaction Methods 0.000 claims abstract description 41
- JPBWZIPCMDZOPM-UHFFFAOYSA-N 2-(4-chlorophenyl)aniline Chemical compound NC1=CC=CC=C1C1=CC=C(Cl)C=C1 JPBWZIPCMDZOPM-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000002904 solvent Substances 0.000 claims abstract description 31
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims abstract description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims abstract description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 15
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims abstract description 15
- 239000003463 adsorbent Substances 0.000 claims abstract description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 10
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 9
- 150000001340 alkali metals Chemical class 0.000 claims abstract description 9
- 239000003849 aromatic solvent Substances 0.000 claims abstract description 7
- 239000003495 polar organic solvent Substances 0.000 claims abstract description 5
- 238000001179 sorption measurement Methods 0.000 claims abstract description 4
- RXTRRIFWCJEMEL-UHFFFAOYSA-N 2-chloropyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1Cl RXTRRIFWCJEMEL-UHFFFAOYSA-N 0.000 claims description 27
- 239000000203 mixture Chemical class 0.000 claims description 20
- 239000007787 solid Substances 0.000 claims description 19
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 150000002825 nitriles Chemical class 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 4
- 229960004592 isopropanol Drugs 0.000 abstract description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 19
- 238000003756 stirring Methods 0.000 description 10
- 239000000460 chlorine Substances 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 238000009472 formulation Methods 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 238000002441 X-ray diffraction Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- -1 benzoyl anilide Chemical class 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 239000011343 solid material Substances 0.000 description 5
- 238000004611 spectroscopical analysis Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000004546 suspension concentrate Substances 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 150000002367 halogens Chemical group 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- TWBPWBPGNQWFSJ-UHFFFAOYSA-N 2-phenylaniline Chemical compound NC1=CC=CC=C1C1=CC=CC=C1 TWBPWBPGNQWFSJ-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 229910002483 Cu Ka Inorganic materials 0.000 description 1
- 229940124186 Dehydrogenase inhibitor Drugs 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical class CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- WLLGXSLBOPFWQV-UHFFFAOYSA-N MGK 264 Chemical class C1=CC2CC1C1C2C(=O)N(CC(CC)CCCC)C1=O WLLGXSLBOPFWQV-UHFFFAOYSA-N 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000005392 carboxamide group Chemical group NC(=O)* 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 150000001934 cyclohexanes Chemical class 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- NYQXIOZBHWFCBU-UHFFFAOYSA-N n-phenylpyridine-3-carboxamide Chemical compound C=1C=CN=CC=1C(=O)NC1=CC=CC=C1 NYQXIOZBHWFCBU-UHFFFAOYSA-N 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000004562 water dispersible granule Substances 0.000 description 1
- 239000004565 water dispersible tablet Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A process of preparing the crystalline modification II of the anhydrate of boscalid comprising: reacting 2-chloro-nicatinoyl chloride with 4'-chloro-biphenyl-2-ylamine in a solvent system while removing from the reaction mixture hydrogen chloride formed during the reaction; and recovering the crystalline modification II of the anhydrate of boscalid from the reaction mixture. Preferably 4'-chloro-biphenyl-2-ylamine is present in the reaction mixture in excess and the solvent system comprises a polar organic solvent and/or an aromatic solvent. For example the solvent system may comprise iso-propanol, acetonitrile, benzene, toluene or dichloromethane. Preferably the hydrogen chloride produced is removed by adsorption using an adsorbent, preferably activated alumina and an alkali metal promoter. Also preferably the reaction is conducted at a temperature of 20-80°C, and the reaction mixture is subsequently cooled to 5-20°C to allow boscalid to crystallize from the reaction mixture.
Description
(54) Title of the Invention: Process for the preparation of boscalid
Abstract Title: Process of preparing the crystalline modification II of the anhydrate of boscalid (57) A process of preparing the crystalline modification II of the anhydrate of boscalid comprising: reacting 2-chloronicatinoyl chloride with 4'-chloro-biphenyl-2-ylamine in a solvent system while removing from the reaction mixture hydrogen chloride formed during the reaction; and recovering the crystalline modification II of the anhydrate of boscalid from the reaction mixture. Preferably 4'-chloro-biphenyl-2-ylamine is present in the reaction mixture in excess and the solvent system comprises a polar organic solvent and/or an aromatic solvent. For example the solvent system may comprise iso-propanol, acetonitrile, benzene, toluene or dichloromethane. Preferably the hydrogen chloride produced is removed by adsorption using an adsorbent, preferably activated alumina and an alkali metal promoter. Also preferably the reaction is conducted at a temperature of 20-80°C, and the reaction mixture is subsequently cooled to 5-20°C to allow boscalid to crystallize from the reaction mixture.
-C2’WS \98'969 ^£'089 ==2ffiiS£6EZS£'9M K- l9i
92798
09Ί.Ι.8
-26'9L6 86'S00l·
89'6L0L £9^^^^^29780^..^,,
92'692L
9E7Z2L
-l7Z86el·
-6S'6ZfrL
1503 17
48’ml· £8'099l·
-999Z9L
Sfr'frZ9L
I 1 1 1 1 I 1 1 1 1 I 1 1 1 1 I 1
LO O LO O cn CT) CO CO
I 1 1 1 1 I 1 1 1 1 I 1 1 1 1 I
LO O LO O co co eouejiiiusuejj. %
I 1 1 1 1 I 1 1 1 1 I 1 1 1 1 I
LO O LO O
LO LO
4000 3500 3000 2500 2000 1500 1000
Wavenumbers (cm-1)
-tt'ess
6ΖΌ09
S2Sfr9ggggg
60'629
29'982 8eZ90fi8-98(H
30492 28718
Z17-S00 ι>08-ζ101
984 L8L __6fr'00frL zss^m
1503 17
SUM 882991 -V9O99V
eOUBHILUSUBJl %
4000 3500 3000 2500 2000 1500 1000
Wavenumbers (cm-1)
Figure 2
PROCESS FOR THE PREPARATION OF BOSCALID
The present invention relates to a process for the preparation of boscalid, in 5 particular to a process for the preparation of crystalline modification II of the anhydrate of boscalid.
The compound 2-chloro-N-(4’chloro[1,1 ’ bi pheny l]-2-y l)-3- py ri di ne carboxamide, having the common name boscalid, has the structural formula I:
Boscalid is a fungicide of the carboxamide group and acts as a succinate dehydrogenase inhibitor (SDHI), a respiratory inhibitor of mitochondria. This class of carboximide compounds and the activity of the compounds was first described in US 4,001,416 and US 5,330,995.
Boscalid is active as a fungicide and is now commercially available in a range of formulations for the treatment of fungal infestations and the resulting disorders.
US 7,087,239 concerns the crystalline hydrates of either nicotinic acid anilide 20 and/or benzoyl anilide derivatives. The synthesis and recovery of the hydrate of boscalid is specifically exemplified in US 7,087,239. The hydrate is described as being obtained by first preparing the anhydrate of boscalid, which is obtained at the end of the synthesis procedure as a solution in hot xylene. Upon cooling, boscalid crystallized from the solution and was dried under vacuum in an oven. The anhydrate is indicated to have the following physical properties:
Molecular weight [g/mol]: Melting point [°C] (DSC): Density [g/mol]:
X-ray reflection (2Θ degree) Cu-Ka
IR absorption [cm'1]:
Water content [%]:
343.2
145.2 1.42
18; 22.5; 9.5; 6
1650 <1
US 7,087,239 discloses that the hydrate can be formed by dissolving the anhydrate in tetrahydrofuran (THF) at 40°C in a solvent and adding the resulting solution to water. The precipitate was isolated from the resulting mixture by filtration and dried, to yield the monohydrate of boscalid. The crystalline modification of the anhydrate of boscalid disclosed in US 7,087,239 is referred to herein as the crystalline modification I of boscalid.
US 7,241,896 concerns a process for producing 2-halogen-pyridinecarboxylic acid amides. The preparation of boscalid is disclosed and exemplified. In the example, boscalid is synthesized by the reaction of 2-chloro-3-nicotinyl chloride II with 2-(4-chlorophenyl)aniline in the presence of water and xylene. After the reaction had been allowed to complete, the aqueous phase was removed. It was then necessary to extract the remaining solution with a hot aqueous solution of sodium carbonate. Boscalid was crystallized by steady cooling of the organic solution, after the extraction with sodium carbonate solution.
We have found that it is hard to mill the crystalline modification of the anhydrate of boscalid disclosed in US 7,087,239 in water. As a consequence, it is not a straightforward task to directly formulate the crystalline modification of boscalid into desired formulations which require grinding and/or milling processes. Such formulations are, for example, granules, encapsulated granules, tablets, waterdispersible granules, water-dispersible tablets, water-dispersible powders or water dispersible powders for seed treatment, dust formulations, and formulations in which the active compound is present in dispersed form, such as, for example, suspension concentrates, oil-based suspension concentrates, suspoemulsions, or suspension concentrates for seed treatment. Hydration of the crystalline modification of boscalid is needed prior to formulating into a suspension concentrate.
US 7,501,384 discloses an alleged novel crystalline modification of the anhydrate of boscalid. The crystalline modification disclosed in US 7,501,384 is referred to herein as the crystalline modification II of boscalid. It is suggested in US 7,501,384 that the crystalline modification II of boscalid is more suitable for making various formulations, which otherwise require prolonged grinding/milling processes.
US 7,501,384 describes that the crystalline modification II of the anhydrate of boscalid may be prepared by a process comprising:
a) dissolving the anhydrate of the crystalline modification I of boscalid in a polar organic solvent or an aromatic hydrocarbon; and
b) precipitation of the anhydrate of the crystalline modification II of boscalid by cooling the solvent.
An alternative process for the preparation of the crystalline modification II of the anhydrate of boscalid disclosed in US 7,501,384 comprises:
a) heating the crystalline modification I of boscalid to above 150°C until 20 melted; and
b) cooling the melt with the addition of seed crystals of the crystalline modification II of boscalid.
US 7,501,384 describes the crystalline modification II of boscalid as having
the following properties: | |
Molecular weight [g/mol]: | 342 |
Melting point [°C] (DSC): | 147.2 |
Heat of fusion [J/g] (DSC): | 106 |
Density [g/cm3]: | 1.457 |
Characteristic IR bands [cm-1]: 868, 917, 1675
The key parameters and the cell matrix obtained from the crystallographic investigations of the crystalline modification II of boscalid using a single crystal diffractometer from Siemens are given in US 7,501,384 as follows:
Class: | Monoclinic |
Space group: | P21/C |
a: | 1162.5(6) pm |
b: | 1134.2(4) pm |
c: | 1283.2(5) pm |
a: | 90° |
β: | 114.52(4)° |
Y: | 90° |
Volume: | 1.5390 nm-3 |
Z: | 4 |
Density (calculated): | 1.481 mg/nr3 |
R1, wR2: | 0.0489; 0.1264 |
The parameters indicated above have the following meanings:
a, b, c = edge lengths of the unit cell;
α, β, γ = corresponding angles; and
Z = number of molecules in the unit cell.
FTIR spectrometry may be used to record IR spectra.
Figure 1 is the IR spectrum of the crystalline modification II of the anhydrate 25 of boscalid; and
Figure 2 is the IR spectrum of the crystalline modification I of the anhydrate of boscalid.
It would be of significant advantage if an improved process for the preparation of the crystalline modification II of the anhydrate of boscalid could be provided, in particular a process that is suitable for applying on a commercial scale, with reproducible yields of the modification II product. Preferably, the process would be simple to operate and easy to control.
Accordingly, there is a need for an improved method for preparing boscalid.
In particular, it would be advantageous if the improved method for preparing boscalid could produce the crystalline modification II of the anhydrate in high yields. It would be a further advantage if the process could be simple to operate. Advantageously, the improved process would employ a minimum of components, preferably components that are easy to handle.
There has now been found an improved process for the preparation of boscalid, in particular crystalline modification II of the anhydrate of boscalid. In particular, a novel process involving the reaction of 2-chloro-nicotinoyl chloride with 4'-chloro-biphenyl-2-ylamine in a solvent system has been found.
According to the present invention there is provided a process for the preparing of the crystalline modification II of the anhydrate of boscalid, the process comprising:
(i) reacting 2-chloro-nicotinoyl chloride with 4'-chloro-biphenyl-2-ylamine in a solvent system while removing from the reaction mixture hydrogen chloride formed during the reaction; and (ii) recovering the crystalline modification II of the anhydrate of boscalid from the reaction mixture produced in step (i).
It has been found that the process of the present invention produces the crystalline modification II of the anhydrate of boscalid in yields. The process advantageously may employ a minimum number of components and is simple to operate, in particular on a large or commercial scale.
In the process of the present invention 2-chloro-nicotinoyl chloride is reacted with 4'-chloro-biphenyl-2-ylamine. The reaction is according to the following general reaction scheme:
O
li
Cl
Cl
2-chloronicotinoyl chloride
4'-chlorobiphenyl-2- boscalid ylamine
Both 2-chloro-nicotinoyl chloride and 4'-chloro-biphenyl-2-ylamine are known compounds and are commercially available.
2-chloro-nicotinoyl chloride and 4'-chloro-biphenyl-2-ylamine may be present in the reaction mixture in any suitable amount. In one preferred embodiment, 4'chloro-biphenyl-2-ylamine is present in a molar excess, to ensure complete reaction of 2-chloro-nicotinoyl chloride. In this embodiment, 4'-chloro-biphenyl-2-ylamine is preferably present in a molar excess of at least 10%, more preferably at least 20%.
A molar excess of up to 50% may be employed, preferably up to 30%. A molar excess of 4'-chloro-biphenyl-2-ylamine of 25% is particularly suitable for many embodiments.
The reaction of 2-chloro-nicotinoyl chloride and 4'-chloro-biphenyl-2-ylamine takes place in the presence of a solvent system. The solvent system is most preferably a single phase solvent system, in particular a single phase organic solvent system. The ability to use a single phase solvent system is a further advantage of the process of the present invention.
The solvent system may comprise one or more suitable solvents. Suitable solvents are organic solvents, including polar organic solvents and aromatic hydrocarbons. Preferred organic solvents include alcohols, including polyols, such as glycols, nitriles, aromatic solvents, halogenated alkanes and mixtures thereof.
Examples of suitable alcohols are Ci to Cs alcohols, preferably Ci to Cs alcohols. The alcohol may be a straight chain or branched aliphatic alcohol, more preferably ethanol, propanol and butanol. The alcohol may be an alicyclic alcohol, for example cyclohexanol. The solvent may comprise a polyol, such as a glycol. Examples of suitable glycols are mono- and polyethylene glycols, preferably ethylene glycol and diethylene glycol. One preferred solvent is iso-propanol.
Examples of suitable nitriles are C3 to Cs nitriles, preferably C3 to Οβ nitriles. Acetonitrile is one preferred nitrile.
Suitable aromatic solvents are benzene, toluene and xylene. Benzene and toluene are two preferred aromatic solvents.
Examples of suitable halogenated alkanes are Ci to Cs halogenated alkanes, preferably Ci to C5 halogenated alkanes, more preferably Ci to C3 halogenated alkanes. The alkane may be a straight chain or branched aliphatic alkane, more preferably a halogenated ethane, propane or butane. The alkane may be an alicyclic alkane, for example a halogenated cyclohexane. Suitable halogen moieties include fluorine, chlorine and bromine, with chlorine being preferred. The alkane may comprise a single halogen moiety or two or more halogen moieties. Examples of suitable halogenated alkanes include dichloromethane.
The above indicated solvents are known in the art and are commercially available.
In step (i) of the process of the present invention, 2-chloro-nicotinoyl chloride is reacted with 4'-chloro-biphenyl-2-ylamine to produce boscalid. The reaction of 2chloro-nicotinoyl chloride with 4'-chloro-biphenyl-2-ylamine produces hydrogen chloride as a by-product. In the process of the present invention, hydrogen chloride is removed from the reaction mixture while the reaction of 2-chloro-nicotinoyl chloride with 4'-chloro-biphenyl-2-ylamine is taking place. In this way, the need to take additional steps to neutralise the hydrogen chloride, such as by the addition of significant quantities of a base, are avoided.
Hydrogen chloride is produced and present in the reaction mixture in the form of a gas and may be removed from the reaction mixture in step (i) in any suitable manner. In one preferred embodiment, the hydrogen chloride is removed from the reaction mixture by adsorption. Suitable adsorbents are known in the art. One preferred adsorbent comprises alumina, in particular activated alumina. The adsorbent may further comprise a promoter, for example an alkali metal. One suitable adsorbent is disclosed in US 5,316,998.
The reaction in step (i) of the process may be conducted at any suitable temperature. Step (i) is conducted at a temperature at which the solvent system is a liquid.
The reaction of 2-chloro-nicotinoyl chloride and 4'-chloro-biphenyl-2-ylamine is preferably conducted at a temperature at which solid boscalid will crystallize as a solid from the solvent system once it has been formed in the reaction. In this way, boscalid produced by the reaction of 2-chloro-nicotinoyl chloride and 4'-chlorobiphenyl-2-ylamine is obtained directly as a solid in the reaction mixture.
Once the reaction of 2-chloro-nicotinoyl chloride with 4'-chloro-biphenyl-2ylamine has been completed, the reaction mixture may be cooled to further crystallize any boscalid remaining in solution in the solvent system. For example, the reaction mixture may be cooled to a temperature at or about room temperature, such as from 10 to 20°C.
In many embodiments, the reaction of 2-chloro-nicotinoyl chloride and 4'chloro-biphenyl-2-ylamine in step (i) is performed at a temperature of greater than 10 °C, more preferably at least 15 °C, still more preferably at least 20°C. In some preferred embodiments, the reaction in step (i) is performed at a temperature of at least 30 °C, more preferably at least 40 °C, still more preferably at least 50 °C, with temperatures above 60 °C being suitable in many embodiments. The reaction temperature in step (i) is below the boiling point of the reaction mixture. Preferably, the temperature is less than 80 °C, still more preferably below 75 °C, more preferably still below 70 °C. A reaction temperature of 65 °C has been found to be suitable in many embodiments.
Once the reaction of 2-chloro-nicotinoyl chloride and 4'-chloro-biphenyl-2ylamine in step (i) of the process has been completed, the boscalid product is recovered from the reaction mixture. For example, boscalid may be recovered from the reaction mixture by crystallization. Solid boscalid produced in step (i) may be recovered by filtration, either before or after crystallization of boscalid from solution. Boscalid may be crystallized from the reaction mixture produced in step (i) using any suitable technique. In one preferred embodiment, boscalid is crystallised from the reaction mixture by reducing the temperature of the reaction mixture sufficiently to cause solid boscalid to crystallize. The temperature at which boscalid will crystallize from the reaction mixture will depend upon the solvent system employed. Typical temperatures for crystallizing boscalid are from 5 to 20 °C. Alternative techniques for recovering boscalid from solution in the reaction mixture are known in the art and include removing solvent from the reaction mixture, for example by use of a vacuum or compressed air, and/or by introducing seeding crystals into the reaction mixture. If seed crystals are employed, they are preferably crystals of crystalline modification II of boscalid.
Once the solid boscalid product has been obtained in the reaction mixture, the solid boscalid product may be recovered. The solid recovered is the crystalline modification II of boscalid. The crystalline modification II of the anhydrate of boscalid may be recovered using any suitable technique, for example by one or a combination of removing the solvent and filtration. The recovered crystalline modification II of boscalid is preferably dried following recovery from the reaction mixture.
As noted above, a particular advantage of the process of the present invention lies in the removal of hydrogen chloride from the reaction mixture as it is produced in step (i). As also noted above, this avoids the need to employ a significant amount of a further component, such as a base, to neutralise the hydrogen chloride. By operating step (i) of the process with an excess of 4'-chloro10 biphenyl-2-ylamine, traces of hydrogen chloride remaining in the reaction mixture are removed by reaction with 4'-chloro-biphenyl-2-ylamine, further improving the efficiency and advantage of the process of the present invention.
Embodiments of the present invention will now be described, for illustration purposes only, by way of the following examples.
In the following examples, the percentages indicated are percentage by weight, unless otherwise stated.
EXAMPLES
Example 1
Boscalid was prepared using the following general reaction sequence:
'N Cl
/
2-chloronicotinoyl 4'-chlorochloride biphenyl-2ylamine
O
A rj '-γ ί·ϊ
II J Η
N Cl boscalid
Cl
3.5 g of 2-chloro-nicotinoyl chloride was dripped into a solution of 5.0 g of 4'chloro-biphenyl-2-ylamine in 30 ml methylene chloride contained in a reaction flask at 20°C. The reaction flask was connected to an external HCL adsorber containing an adsorbent comprising activated alumina and an alkali metal promoter. The mixture the reaction flask was maintained at 20°C for 2 hours with stirring.
The resulting mixture was then cooled with stirring to 10°C and boscalid solid allowed to crystallize out of solution. The boscalid solid was recovered in an amount equivalent to a yield of 90% based on the 2-chloro-nicotinoyl chloride used.
The form of the boscalid in the resulting solid material was confirmed as being the crystalline modification II of the anhydrate of boscalid by melting point analysis (DSC), infrared (IR) spectrometry and X-ray diffraction (XRD).
Example 2
Boscalid was prepared following the same general reaction sequence as in Example 1 above.
3.5 g of 2-chloro-nicotinoyl chloride was dripped into a solution of 5.0 g of 4'chloro-biphenyl-2-ylamine in 30 ml benzene contained in a reaction flask at room temperature. The reaction flask was connected to an external HCL adsorber containing an adsorbent comprising activated alumina and an alkali metal promoter. The mixture was then heated to 40 °C and maintained at this temperature for 2 hours with stirring.
The resulting mixture was then cooled with stirring to room temperature and boscalid solid allowed to crystallize out of solution. The boscalid solid was recovered from the reaction mixture in an amount equivalent to a yield of 92% based on the 2chloro-nicotinoyl chloride used.
The form of the boscalid in the resulting solid material was confirmed as being the crystalline modification II of the anhydrate of boscalid by melting point analysis (DSC), infrared (IR) spectrometry and X-ray diffraction (XRD).
Example 3
Boscalid was prepared following the same general reaction sequence as in
Example 1 above.
3.5 g of 2-chloro-nicotinoyl chloride was dripped into a solution of 5.0 g of 4'chloro-biphenyl-2-ylamine in 30 ml iso-propanol held in a reaction flask at 40 °C. The reaction flask was connected to an external HCL adsorber containing an adsorbent comprising activated alumina and an alkali metal promoter. The mixture was then heated to 65 °C and maintained at this temperature for 2 hours with stirring.
The resulting mixture was then cooled with stirring to room temperature and boscalid solid allowed to crystallize out of solution. The boscalid solid was recovered in an amount equivalent to a yield of 95% based on the 2-chloro-nicotinoyl chloride used.
The form of the boscalid in the resulting solid material was confirmed as being the crystalline modification II of the anhydrate of boscalid by melting point analysis (DSC), infrared (IR) spectrometry and X-ray diffraction (XRD).
Example 4
Boscalid was prepared following the same general reaction sequence as in Example 1 above.
3.5 g of 2-chloro-nicotinoyl chloride was dripped into a solution of 5.0 g of 4'chloro-biphenyl-2-ylamine in 30 ml acetonitrile held in a reaction flask at 40 °C. The reaction flask was connected to an external HCL adsorber containing an adsorbent comprising activated alumina and an alkali metal promoter. The mixture was then heated to 65 °C and maintained at this temperature for 2 hours with stirring.
The resulting mixture was then cooled with stirring to room temperature and boscalid solid allowed to crystallize out of solution. The boscalid solid was recovered in an amount equivalent to a yield of 95% based on the 2-chloro-nicotinoyl chloride used.
The form of the boscalid in the resulting solid material was confirmed as being the crystalline modification II of the anhydrate of boscalid by melting point analysis (DSC), infrared (IR) spectrometry and X-ray diffraction (XRD).
Example 5
Boscalid was prepared following the same general reaction sequence as in Example 1 above.
3.5 g of 2-chloro-nicotinoyl chloride was dripped into a solution of 5.0 g of 4'chloro-biphenyl-2-ylamine in 30 ml toluene held in at room temperature. The reaction flask was connected to an external HCL adsorber containing an adsorbent comprising activated alumina and an alkali metal promoter. The mixture was then heated to 65 °C and maintained at this temperature for 2 hours with stirring.
The resulting mixture was then cooled with stirring to room temperature and boscalid solid allowed to crystallize out of solution. The boscalid solid was recovered in an amount equivalent to a yield of 92% based on the 2-chloro-nicotinoyl chloride used.
The form of the boscalid in the resulting solid material was confirmed as being the crystalline modification II of the anhydrate of boscalid by melting point analysis (DSC), infrared (IR) spectrometry and X-ray diffraction (XRD).
Claims (18)
1. A process for the preparing of the crystalline modification 11 of the anhydrate of boscalid, the process comprising:
(i) reacting 2-chloro-nicotinoyl chloride with 4'-chloro-biphenyl-2-ylamine in a solvent system while removing from the reaction mixture hydrogen chloride formed during the reaction; and (ii) recovering the crystalline modification II of the anhydrate of boscalid from the reaction mixture produced in step (i).
2. The process according to claim 1, wherein 4'-chloro-biphenyl-2-ylamine is present in the reaction mixture of step (i) in excess.
3. The process according to claim 2, wherein 4'-chloro-biphenyl-2-ylamine is present in a molar excess of at least 10%.
4. The process according to claim 3, wherein 4'-chloro-biphenyl-2-ylamine is present in a molar excess of at least 20%.
5. The process according to claim 4, wherein 4'-chloro-biphenyl-2-ylamine is present in a molar excess of about 25%.
6. The process according to any preceding claim, wherein the solvent system is a single phase organic solvent system.
7. The process according to any preceding claim, wherein the solvent system comprises a polar organic solvent and/or an aromatic solvent.
8. The process according to claim 7, wherein the solvent system comprises an alcohol, a nitrile, an aromatic solvent, a halogenated alkane, or a mixture thereof.
9. The process according to claim 8, wherein the solvent system comprises isopropanol, acetonitrile, benzene, toluene, dichloromethane, or a mixture thereof.
10. The process according to any preceding claim, wherein hydrogen chloride produced in step (i) is removed by adsorption using an adsorbent.
11. The process according to claim 10, wherein the adsorbent comprises activated alumina.
12. The process according to either of claims 10 or 11, wherein the adsorbent comprises an alkali metal promoter.
13. The process according to any preceding claim, wherein step (i) is conducted at a temperature at which solid boscalid will crystallize from the reaction mixture.
14. The process according to any preceding claim, wherein step (i) is conducted at a temperature of at least 20°C.
15. The process according to any preceding claim, wherein step (i) is conducted at a temperature of up to 80°C.
16. The process according to any preceding claim, wherein step (ii) comprises cooling the reaction mixture produced in step (i) to allow boscalid to crystallize from the reaction mixture.
17. The process according to claim 16, wherein the reaction mixture is cooled to a temperature of from 5 to 20°C.
18. A process for the preparation of the crystalline modification II of the anhydrate of boscalid substantially as hereinbefore described.
Intellectual
Property
Office
Application No: GB1613458.7 Examiner: Helen Yard
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1613458.7A GB2552697B (en) | 2016-08-04 | 2016-08-04 | Process for the preparation of boscalid |
CN201780045903.3A CN109476604A (en) | 2016-08-04 | 2017-07-27 | The method for being used to prepare Boscalid |
PCT/CN2017/094628 WO2018024146A1 (en) | 2016-08-04 | 2017-07-27 | Process for preparation of boscalid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1613458.7A GB2552697B (en) | 2016-08-04 | 2016-08-04 | Process for the preparation of boscalid |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2552697A true GB2552697A (en) | 2018-02-07 |
GB2552697B GB2552697B (en) | 2021-03-10 |
Family
ID=60940411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1613458.7A Expired - Fee Related GB2552697B (en) | 2016-08-04 | 2016-08-04 | Process for the preparation of boscalid |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN109476604A (en) |
GB (1) | GB2552697B (en) |
WO (1) | WO2018024146A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7241896B2 (en) * | 2001-11-02 | 2007-07-10 | Basf Aktiengesellschaft | Method for producing 2-halogen-pyridine-carboxylic acid amides |
CN103073489A (en) * | 2013-02-06 | 2013-05-01 | 利民化工股份有限公司 | Preparation method of Boscalid |
CN103980192A (en) * | 2014-01-20 | 2014-08-13 | 泰州百力化学股份有限公司 | Selective synthesis method of cyprosulfamide with different crystal forms |
WO2014174397A2 (en) * | 2013-04-25 | 2014-10-30 | Mandal Dr Swadhin K | Method of synthesis molecules using catalyst and composites thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5316998A (en) * | 1992-05-05 | 1994-05-31 | Discovery Chemicals, Inc. | HCl adsorbent and method for making and using same |
CN1275943C (en) * | 2001-09-25 | 2006-09-20 | 巴斯福股份公司 | Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives |
DE10307751A1 (en) * | 2003-02-14 | 2004-08-26 | Basf Ag | New monoclinic boscalide crystal modification with defined melting point useful as herbicide |
CN106103404B (en) * | 2014-01-17 | 2017-11-24 | 迈克斯(如东)化工有限公司 | The preparation and application of biphenol compound |
-
2016
- 2016-08-04 GB GB1613458.7A patent/GB2552697B/en not_active Expired - Fee Related
-
2017
- 2017-07-27 WO PCT/CN2017/094628 patent/WO2018024146A1/en active Application Filing
- 2017-07-27 CN CN201780045903.3A patent/CN109476604A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7241896B2 (en) * | 2001-11-02 | 2007-07-10 | Basf Aktiengesellschaft | Method for producing 2-halogen-pyridine-carboxylic acid amides |
CN103073489A (en) * | 2013-02-06 | 2013-05-01 | 利民化工股份有限公司 | Preparation method of Boscalid |
WO2014174397A2 (en) * | 2013-04-25 | 2014-10-30 | Mandal Dr Swadhin K | Method of synthesis molecules using catalyst and composites thereof |
CN103980192A (en) * | 2014-01-20 | 2014-08-13 | 泰州百力化学股份有限公司 | Selective synthesis method of cyprosulfamide with different crystal forms |
Also Published As
Publication number | Publication date |
---|---|
GB2552697B (en) | 2021-03-10 |
CN109476604A (en) | 2019-03-15 |
WO2018024146A1 (en) | 2018-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005289099B2 (en) | Process for the preparation of 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide | |
US7999106B2 (en) | Processes for the preparation of clopidogrel hydrogen sulfate polymorphic form I | |
CN108947891B (en) | Method for safely preparing pimavanserin and tartrate thereof by using triphosgene | |
AU2012380672B2 (en) | Process for preparing crystalline Sorafenib tosylate | |
CA2988594C (en) | Methods of making protein deacetylase inhibitors | |
US10364225B2 (en) | Process for preparing boscalid | |
AU2002241764A1 (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof | |
TWI756173B (en) | Process for preparing boscalid | |
US9278932B1 (en) | Process for preparation of 2-chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide solid forms | |
WO2018024146A1 (en) | Process for preparation of boscalid | |
TWI733869B (en) | Process for preparing boscalid | |
WO2019085681A1 (en) | Process for the preparation of thiamethoxam | |
TW201643142A (en) | Process for preparing boscalitd | |
TWI777967B (en) | Process for preparing boscalid | |
EP2938605A2 (en) | Process for preparing amorphous cabazitaxel | |
WO2012150183A1 (en) | Crystalline sodium salt of an hiv integrase inhibitor | |
WO2021134943A1 (en) | Flazasulfuron crystal form and preparation method therefor | |
CN111004216A (en) | Flazasulfuron crystal form and preparation method thereof | |
TW202237594A (en) | Process for the production of 5-(4-((2s,5s)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1h-1,2,4-triazol-3-amine | |
JP4968602B2 (en) | Method for producing benzamide derivative | |
CN111116557A (en) | Flazasulfuron crystal form and preparation method thereof | |
JPH06211840A (en) | Production of phthalazone derivative | |
US20070197576A1 (en) | Production of Cabergoline and Novel Polymorphic Form Thereof | |
JPS588049A (en) | Preparation of beta-chloroalanine | |
WO2008013248A1 (en) | Process for production of (±)-trans-4-(4- fluorophenyl)-3-hydroxymethylpiperidine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20230804 |